2024年欧洲肿瘤内科学会亚洲年会（ESMO Asia Congress）肝胆胰肿瘤研究热点与前沿动态

Highlights and cutting-edge advances in hepatobiliary and pancreatic cancer research at the European Society of Medical Oncology (ESMO) Asia Congress 2024

摘要:

2024年欧洲肿瘤内科学会亚洲年会于2024年12月6日—8日在新加坡召开。大会公布了多项关于肝胆胰肿瘤领域的重磅研究，涵盖了新辅助治疗、辅助治疗、转化治疗、后线治疗以及肿瘤标志物等相关内容的临床应用。这些研究为肝胆胰恶性肿瘤的临床诊疗提供了新的思路并推动相关领域的发展。本文聚焦本次大会肝胆胰恶性肿瘤的重点内容，旨在解读肝胆胰肿瘤领域的前沿成果，探讨相关领域的热点问题和未来发展的方向。

Abstract:

The European Society for Medical Oncology Asia Congress 2024 was held in Singapore from December 6 to 8, 2024. The conference unveiled several groundbreaking studies in the field of hepatobiliary and pancreatic tumors, covering clinical applications related to neoadjuvant and adjuvant therapies, translational treatments, later-line therapies, and tumor biomarkers. These studies provide new insights into the clinical diagnosis and treatment of hepatobiliary and pancreatic malignancies and drive the development of related fields. This article focuses on the key topics in hepatobiliary and pancreatic malignancies presented at the conference, aiming to interpret the latest advances in the field and explore the hot issues and future directions for development in this area.